- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06264089
Effects of Preservation Rhinoplasty Nasal Valve Angle and Area
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Van, Turkey, 65080
- Yaser Said Cetin
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Preservation rhinoseptoplasty
Exclusion Criteria:
- Absence of nasal obstruction
- Previous nasosinusal surgery
- Cranio-facial anomalies
- Presence of nasosinusal tumors
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: No Arms have been specified for this study
|
The same group of patients who underwent Preservation Rhinoplasty will be followed and the nasal valve angles before and after surgery will be compared.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Nasal Obstruction Symptom Evaluation Scale (NOSE)
Time Frame: 12 month
|
Nasal Obstruction Symptom Evaluation Scale (NOSE) The NOSE will be used to measure the quality of life related to nasal obstruction. It is a validated instrument specifically designed for use in patients with nasal obstruction. According to this scale patients are asked to evaluate difficulty breathing in a general way and specifically the difficulty in breathing through the nose, breathing during sleep, and severity of their nasal congestion. The severity of the symptoms is recorded on a scale of 0 to 4, with 0 being the absence of a problem and 4 being a serious problem. The possible scores range from 0 to 20 and the higher scores indicate a higher degree of nasal obstruction. The sum of the scores is multiplied by 5 so as to obtain a final score ranging from 0 to 100, with higher values associated with poorer quality of life. The scale will be applied at the base line and at the end of 12 months. |
12 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Reformatted coronal Computed tomography
Time Frame: 12 month
|
The internal and external nasal valve levels of patients scheduled for septorhinoplasty surgery will be prospectively examined preoperatively and postoperatively with a high-resolution 3-plan (axial-sagittal-coronal) CT study. Axial CT studies will be obtained with the latest generation, 128-channel, multi-slice CT scanners (Siemens SOMATOM Definition AS+128, Forchheim, Germany) with a slice thickness of 0.5 to 1.25 mm in the bone algorithm. Axial slices will be acquired from the top of the frontal sinuses to the bottom of the maxillary incisors. Studies will be made from random selections and without correlation to diagnosis or indication. Axial data will be transferred to the workstation (Siemens Syngo Via Workstation) for postprocessing and measurements will be performed on this workstation. |
12 month
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 202015
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Nasal Obstruction, Bilateral
-
HNO-Praxis Alte PostAerin MedicalCompletedNasal Obstruction, BilateralGermany
-
Spirair, IncRecruitingNasal Airway Obstruction | Nasal Septal DeviationUnited States
-
Aerin MedicalOhio State UniversityCompletedNasal ObstructionUnited States
-
Aerin MedicalActive, not recruitingNasal ObstructionUnited States
-
Medtronic Surgical TechnologiesCompletedNasal Airway ObstructionUnited States, Canada
-
Aerin MedicalActive, not recruitingNasal Airway ObstructionUnited States
-
New York City Health and Hospitals CorporationUnknownNasal Airway ObstructionUnited States
-
Aerin MedicalCompletedNasal ObstructionUnited States
-
Aerin MedicalCompleted
-
Philips Clinical & Medical Affairs GlobalKarolinska University HospitalNot yet recruitingOxygen | SpO2 | Nasal Alar Collapse, Bilateral | Measurement
Clinical Trials on Preservation Rhinoplasty Nasal Valve Angle and Area
-
Suez Canal UniversityNational Research Centre, EgyptCompletedMitral Valve Replacement | Diseases of Mitral Valves | Abnormality of Mitral Valve Annulus (Disorder)Egypt
-
Tanta UniversityRecruiting
-
Poitiers University HospitalCompleted
-
Milton S. Hershey Medical CenterNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
Virginia Commonwealth UniversityWithdrawnApical Periodontitis | Caries,Dental
-
Hospital de Clinicas de Porto AlegreUnknownCommon Cold | Flu-like SyndromeBrazil
-
GlaxoSmithKlineCompleted
-
FibroGenCompletedIdiopathic Pulmonary FibrosisUnited States, New Zealand, India, South Africa, Australia, Bulgaria, Canada
-
Vanderbilt University Medical CenterUMC UtrechtCompleted